Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel ZAl1-AR-M-J1: NOT-02-023: Biodefense And Emerging Infectious Diseases.
Date: October 28, 2002.
Time: 3:30 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications and/or proposals.
Place: 6700 B Rockledge Dr, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Alec Ritchie, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2223, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-2550 email@example.com.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
September 27, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-25237 Filed 10-3-02; 8:45 am]
BILLING CODE 4140-01-M